Contemporary outcomes of surgical ventricular septal defect closure

Brett R Anderson1, Kristen N Stevens, Susan C Nicolson

  • 1Department of Pediatrics, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Insights

In pediatric cardiac surgery, infant weight significantly impacts outcomes for ventricular septal defect (VSD) repair. Lower weight in infants undergoing VSD closure correlates with increased risk and longer hospital stays.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Defects
  • Surgical Outcomes Research

Background:

  • Surgical closure of ventricular septal defects (VSDs) is a common pediatric cardiac procedure.
  • Limited contemporary data exists on risk factors and non-mortality outcomes for VSD repair.
  • Understanding these factors is crucial for optimizing patient care.

Purpose of the Study:

  • To assess baseline characteristics and outcomes of children undergoing surgical repair of VSDs.
  • To identify risk factors and drivers of morbidity in a contemporary cohort.
  • To analyze the impact of patient weight on VSD repair outcomes.

Main Methods:

  • Retrospective analysis of 369 consecutive VSD closures at a single institution.
  • Focus on morbidity due to low mortality rates.
  • Multivariable linear regression modeling to identify risk drivers.

Main Results:

  • For infants < 6 months, each kilogram increase in operative weight reduced length of stay by 2.3 days.
  • Infants < 6 months with VSD repair showed a 1.8-fold increased composite risk for each kilogram decrease in weight.
  • No significant difference in risk was observed for patients > 6 months based on weight.

Conclusions:

  • Infant weight is a significant predictor of morbidity and length of stay after VSD closure.
  • Weight should be a key consideration when discussing operative risks for young infants undergoing VSD repair.
  • These findings are relevant irrespective of the specific indication for VSD surgery.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...